Megna Michael R Insider Trading Activity
6
Total trades
$3.6M
Total volume
Apr 9, 2026
Last activity
Kiniksa Pharmaceuticals International, plc
Megna Michael R has been net-selling over the last 12 months with 0 purchases and 5 sales across 1 company.
KNSA is the most-traded position with 5 trades. The largest single transaction was a sale of KNSA for $1.4M on Oct 20, 2025.
Performance Scorecard
Forward stock performance after each transaction by Megna Michael R. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -9.7% | 17% | 6 |
| 90 days | — | -12.1% | 0% | 5 |
| 120 days | — | -22.3% | 0% | 5 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersKNSA · Kiniksa Pharmaceuticals International, plc
🔒 Subscribe to see trade entries
Pro members see exactly when Megna Michael R bought and sold KNSA.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | ROLE |
|---|---|---|---|---|---|---|
| Apr 9, 2026 | KNSA | Sell | 6,625 | $46.69 | $309K | CHIEF ACCOUNTING OFFICER |
| Oct 20, 2025 | KNSA | Sell | 37,255 | $38.72 | $1.4M | CHIEF ACCOUNTING OFFICER |
| Oct 20, 2025 | KNSA | Sell | 13,235 | $39.31 | $520K | CHIEF ACCOUNTING OFFICER |
| Sep 3, 2025 | KNSA | Sell | 11,000 | $34.84 | $383K | CHIEF ACCOUNTING OFFICER |
| Aug 4, 2025 | KNSA | Sell | 17,000 | $32.35 | $550K | CHIEF ACCOUNTING OFFICER |
| Jun 3, 2025 | KNSA | Sell | 15,211 | $28.75 | $437K | CHIEF ACCOUNTING OFFICER |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| KNSA | Kiniksa Pharmaceuticals International, plc | 6 | $3.6M |
Other insiders at Kiniksa Pharmaceuticals International, plc
7 other tracked filers at KNSA.